Prospective Study
Copyright ©The Author(s) 2025.
World J Crit Care Med. Sep 9, 2025; 14(3): 105428
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.105428
Table 4 Viral etiology concerning mortality and survival rate
Viral serologyOutcome, n (%)
P value
Died (n = 70)
Survived (n = 32)
AIH0.001a
Yes-6 (18.8)
No70 (100)26 (81.3)
Anti-HAV IgM0.002a
Reactive19 (27.1)-
Non-Reactive51 (72.9)32 (100)
HBs Ag0.173
Reactive6 (8.6)-
Non-Reactive64 (91.4)32 (100)
HBc IgM 0.95
Reactive7 (10)-
Non-reactive63 (90)32 (100)
HEV IgM0.000a
Reactive51 (72.9)32 (100)
Non-Reactive19 (27.1)-
Anti-HCV Ab0.105
Reactive6 (8.6)7 (21.9)
Non-reactive64 (91.4)25 (78.1)